Pharmaceutical Sterility Testing Market Expansion Forecast Reaching $4.65 Billion By 2030 At 22.2% CAGR
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Pharmaceutical Sterility Testing Market Expected To Change From 2026 To 2030?
The size of the pharmaceutical sterility testing market has expanded significantly over recent years. Projections indicate it will increase from $1.68 billion in 2025 to $2.07 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 23.7%. Historically, this growth has been driven by factors such as the rising demand for sterile pharmaceutical products, the scarcity of sophisticated testing laboratories, the expansion of pharmaceutical production and biologics pipelines, the continued dependence on traditional sterility testing approaches, and a heightened understanding of quality control benchmarks.
The pharmaceutical sterility testing market size is anticipated to experience substantial growth in the forthcoming years. It is expected to expand to $4.91 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 24.1%. This projected growth during the forecast period is attributed to progress in automated sterility testing technologies, the broadening of outsourcing testing services, the incorporation of AI and digital monitoring tools, the rising adoption of rapid microbiological methods, and increasing regulatory requirements for biologics and gene therapies. Furthermore, prominent trends for the forecast period include an escalating demand for both in-house and outsourced sterility testing services, the increasing prevalence of bioburden and endotoxin testing in pharmaceutical manufacturing, a greater utilization of sophisticated instruments, kits, and reagents for sterility analysis, an expansion of testing provisions for biologics, vaccines, gene, and cell therapies, and a reinforced emphasis on adherence to regulations and quality assurance in sterility testing.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2826&type=smp
Which Key Drivers Are Affecting The Pharmaceutical Sterility Testing Market Development?
The escalating sales of biologics are anticipated to invigorate the pharmaceutical sterility testing market. Biologics, encompassing various products such as vaccines, blood components, and gene therapies, are medicines derived from living organisms. Pharmaceutical sterility testing is crucial for quality control, verifying that these biologics are free from microbial contamination before patient administration. For instance, in October 2024, the Generics and Biosimilars Initiative, an organization based in Belgium providing scientific information on medicines, highlighted that in addition to the nine primary biologics, two other intricate drugs achieved substantial sales in 2023. Novo Nordisk’s Ozempic (semaglutide) and Eli Lilly’s Trulicity (dulaglutide), both prescribed for type 2 diabetes, recorded sales of US$14 billion and US$7.2 billion, respectively. This demonstrates how the growth in biologics sales is acting as a key driver for the pharmaceutical sterility testing market.
How Is The Pharmaceutical Sterility Testing Market Broken Down By Segment Categories?
The pharmaceutical sterility testing market covered in this report is segmented –
1) By Sample: Sterile Drugs, Medical Devices, Biologics and Therapeutics
2) By Product Type: Instruments, Kits and Reagents, Services
3) By Service Type: In- house, Outsourcing
4) By Test Type: Sterility Testing, Bioburden Testing, Bacterial Endotoxin Testing
5) By End- User: Compounding Pharmacies, Medical Devices Companies, Pharmaceutical Companies
Subsegments:
1) By Sterile Drugs: Injectable Drugs, Infusion Solutions, Ophthalmic Solutions
2) By Medical Devices: Surgical Instruments, Implants, Catheters
3) By Biologics And Therapeutics: Vaccines, Gene Therapies, Cell Therapies
What Trends Are Influencing The Evolution Of The Pharmaceutical Sterility Testing Market?
Major companies operating in the pharmaceutical sterility testing market are concentrating on developing innovative solutions, including Advanced biological indicators, to accelerate sterility confirmation, improve testing accuracy, and enhance overall manufacturing safety. Advanced biological indicators are specialized instruments containing highly resistant microorganisms that rapidly and accurately verify the effectiveness of sterilization processes in pharmaceutical manufacturing. For instance, in September 2025, Nelson Labs, a US-based contract testing laboratory, introduced the RapidCert Biological Indicator (BI) sterility testing platform. This new system significantly reduces the time required to confirm sterility, thereby boosting efficiency in pharmaceutical manufacturing and supporting faster product release while adhering to rigorous quality standards.
Which Players Are Present In The Pharmaceutical Sterility Testing Market Space?
Major companies operating in the pharmaceutical sterility testing market are Pacific Biolabs Inc., STERIS Corporation, Boston Analytical Inc., Gibraltar Laboratories Inc., Sartorius AG, Solvias AG, SGS S.A., Toxikon Inc., Pace Analytical Services LLC, Charles River Laboratories International Inc., Nelson Laboratories Inc., Rapid Micro Biosystems Inc., bioMérieux Inc., Merck KGaA, WuXi AppTec, Sotera Health LLC, Dynalabs LLC, Infinity Laboratories, Eurofins Scientific SE, Avomeen Analytical Services, Microbac Laboratories Inc., Analytical Lab Group LLC, North American Science Associates Inc., Medical Device Testing Services Inc., Microtest Laboratories Inc., BioScreen Testing Services Inc., Microchem Laboratory Inc., Bactolac Pharmaceutical Inc., Micro Quality Labs Inc., BioPharma Services Inc., Microbiology Research Associates, BioScience Laboratories Inc.
Get The Full Pharmaceutical Sterility Testing Market Report:
Which Region Is The Top Contributor To The Pharmaceutical Sterility Testing Market By Share?
North America was the largest region in the pharmaceutical sterility testing market in 2025. The Middle East is expected to be the fastest-growing region in the global pharmaceutical sterility testing market share during the forecast period. The regions covered in the pharmaceutical sterility testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Pharmaceutical Sterility Testing Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Pharmaceutical Sterility Testing Market 2026, By The Business Research Company
Pharmaceutical Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-report
Pharmaceutical Excipient Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report
Pharmaceutical Packaging Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
